搜尋結果
（星期二）上午九時正至下午一時正前往香港股份過戶登記處香港中央證券登記有限公 司（地址為香港灣仔皇后大道東 183號合和中心17樓1712至1716號舖）領取其相關退款支 票。合資格親自領取的個人申請人不得授權任何其他人士代為領取。符合親自領取資格
- Breakdown of Hong Kong Pharmaceutical Market by Product Categories, 2019
- Our Branded Healthcare Product Portfolio
- Distribution Channels
- Manufacturer
- Entry Barriers
- Future Trends
- Future trends
- More cross-border e-commerce pilot zones:
- POTENTIAL MARKET IMPACT FROM THE OUTBREAK OF COVID-19
Chinese medicines Western medicines Source: Frost & Sullivan Report
Our portfolio of branded healthcare products are broadly divided into two product categories, namely consumer healthcare and proprietary Chinese medicines. Our consumer healthcare products are further categorized into: (i) branded medicines (primarily OTC proprietary medicines, which fall within the classification of Western medicines in Hong Kong)...
Most branded healthcare companies adopt a multi-channel distribution strategy to reach a wider group of consumers. Major distribution channels for branded healthcare companies in Hong Kong include (i) trading companies; (ii) non-chain retail stores (such as registered pharmacies and drug stores); (iii) chain retail stores (such as supermarkets, con...
Overseas Distributors • Relevant registration can be conducted by distributors or agents, such as product registration and trade mark registration. Source: Frost & Sullivan Report The following table sets forth the major chain retailers in Hong Kong: Retail chain 7-Eleven . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....
The major entry barriers of the Hong Kong branded healthcare market are as follows: Sourcing: Established companies are prone to obtain distribution rights to high quality products from reputable local or overseas suppliers, due to their regional influence, proven track record of existing products and sufficient capacity to increase their portfolio...
The major future trends of the Hong Kong branded healthcare market are as follows: Product customization and increasing prevalence: Increasing health awareness has widened the consumer base of branded healthcare products to include people of all ages. To cater for the needs of consumers of different ages and differentiate from competitors, product ...
Going forward, cross-border e-commerce for healthcare products is expected to continue to increase. The major future trends are as follows:
An increasing number of cross-border e-commerce pilot zones are expected to be set up across China to cater for the strong demand in China for overseas healthcare products, which in turn will lead to a growth in the import market of healthcare products. Involvement of multinational companies: Current cross-border e-commerce landscape primarily cons...
The COVID-19 outbreak has impacted the branded healthcare market in Hong Kong in various aspects. In particular, various social-distancing measures, travel restrictions and mandatory quarantine requirements implemented from time to time in an effort to contain the outbreak have caused a decline in local economic activities. For example, the tempora...
– 2 – 2021 2020 NOTE HK$’000 HK$’000 Other comprehensive income Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign operations 67,025 137,672 Total comprehensive income for the year 406,260 470,236
– 2 – 2020 2019 NOTE HK$’000 HK$’000 Other comprehensive income (expense) Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign operations 137,672 (42,564) Total comprehensive income for the year 470,236 236,354
– 4 – CONSOLIDATED STATEMENT OF FINANCIAL POSITION As at 31 December 2023 2023 2022 Notes RMB’000 RMB’000 Non-current assets Property, plant and equipment 944 379,719 Interests in leasehold land held for own use – 115,998 Intangible assets 195 158,985
The Company is a limited liability company incorporated in Hong Kong. The registered office of the Company is situated at Level 6, Three Pacific Place, 1 Queen’s Road East, Hong Kong. The Group was involved in wealth management, enterprise finance, institutional services and trading, asset management and other business.
求於合理時間內前往香港與聯交所會面；(d) 我們已根據《上市規則》第3A.19 條委聘合規顧問提供服務。合規顧問將（包 括）充當本公司授權代表以外的額外溝通渠道。合規顧問將向本公司提供有 關持續遵守《上市規則》的專業意見，並可回應聯交所的查詢。
